Valsts: Īrija
Valoda: angļu
Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)
Chlortetracycline; Sulphanilamide
Vetoquinol Ireland Limited
QD06AA52
Chlortetracycline; Sulphanilamide
2.85, 50 gram/100gram
Cutaneous spray, powder
POM: Prescription Only Medicine as defined in relevant national legislation
Cattle, Dogs, Goats, Horses, Sheep
chlortetracycline, combinations
Antibacterial
Authorised
1988-10-11
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Orospray 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Cutaneous spray, powder. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses, Cattle, Goat, Sheep and Dog. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the topical treatment of wounds infected by organisms sensitive to the active ingredients. For the prevention and treatment of post operative infections following surgical procedures by topical application. 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to one of the ingredients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. Each 100g powder contains : Active substances: Chlortetracycline (as hydrochloride) 2.850 g Sulfanilamide 50.000 g Excipients: Methyl parahydroxybenzoate 0.115 g H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _1_ _4_ _/_ _0_ _8_ _/_ _2_ _0_ _1_ _5_ _C_ _R_ _N_ _ _ _7_ _0_ _2_ _1_ _6_ _0_ _0_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTION(S) FOR USE IN ANIMALS Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE MEDICINAL PRODUCT TO ANIMALS Pressurised co Izlasiet visu dokumentu